Shoulder Innovations Doubles Customer Growth, Sets Sights on Surgical Robotics
Shoulder Innovations (NYSE:SI) reported doubling customer growth and highlighted its InSet Glenoid implant's 100% survivorship rate. The company also discussed its integrated surgical system, AI planning tool, and plans to file a 510(k) submission for a robotic system in 2027. It estimates the U.S. market for shoulder procedures at $5 billion.





